The HSPG2 gene gives your body instructions for making perlecan, a protein that helps support cartilage, muscles, blood vessels, and other tissues. This gene plays an important role in keeping growing bones and joints structured and helping tissues handle physical stress. If the HSPG2 gene does not work properly, people may have a condition affecting bone growth, short stature, joint changes, and muscle stiffness. Certain variants in the HSPG2 gene are linked to Schwartz-Jampel syndrome and a much rarer skeletal condition present from birth.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
HSPG2Gene function
What if the gene works
The HSPG2 gene provides instructions for perlecan, a protein that helps support cartilage, blood vessels, and thin tissue layers that hold cells in place. It also helps tissues stay strong and supports growth signals during development.
Risk
What if the gene does not work
Variants in the HSPG2 gene can affect bone, cartilage, and muscle development. Milder variants are linked to Schwartz-Jampel syndrome, with muscle stiffness and short stature, while more severe variants can cause a much more severe skeletal condition present before birth.
Treatment
What does that mean for your treatment
No HSPG2-specific treatment or drug choice is currently established in clinical guidelines. Management is symptom based and may include supportive orthopedic, rehabilitation, anesthesia, and muscle symptom care rather than a treatment directed at the HSPG2 gene itself. The HSPG2 gene is also being studied in tissue repair and cancer biology, but this has not led to guideline-based therapies.
Conditions associated with HSPG2
Gene function
What if the gene works
Your tissues need firm but flexible support to keep their shape and work smoothly. The HSPG2 gene helps make perlecan, a large support protein that sits outside cells in thin tissue linings and connective tissue. This is a key part of how the HSPG2 gene supports connective tissue throughout the body.
Perlecan helps build thin support layers called basement membranes and the wider material around cells. It gives tissues structure, helps them stay organized, and creates a steady surface that cells can attach to.
Perlecan holds chemical messages near cells and helps present them at the right place. This supports normal cell growth, movement, and routine tissue upkeep.
Perlecan draws water into the material around cells. This helps tissues stay springy, supports smooth joint surfaces, and spreads pressure more evenly during everyday movement.
In thin tissue linings, perlecan helps form selective barriers between neighboring areas. These barriers guide the movement of water, proteins, and other molecules while helping the tissue stay stable.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including traits such as appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not cause any noticeable changes and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the HSPG2 gene can alter perlecan, a large support protein outside cells, so less is made, it breaks down sooner, or it cannot connect normally. Milder variants may leave some protein activity, while more severe variants can sharply reduce or nearly eliminate it. This range helps explain how HSPG2 gene variants affect protein function, with partial loss often linked to Schwartz-Jampel syndrome and near-complete loss to the earlier, more severe skeletal condition dyssegmental dysplasia, Silverman-Handmaker type.
How variants are linked to conditions
Pathogenic variants in the HSPG2 gene cause Schwartz-Jampel syndrome type 1 and the more severe skeletal condition dyssegmental dysplasia, Silverman-Handmaker type. People with Schwartz-Jampel syndrome often have muscle stiffness and bone and joint changes, while dyssegmental dysplasia causes major bone growth problems beginning before birth. When reading about conditions linked to HSPG2 gene variants, these are the main, well-established diagnoses.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HSPG2, risk is mainly changed by inheritance, not lifestyle. A child’s chance of having an HSPG2-related condition is higher when both biological parents carry a harmful HSPG2 change, and this can be more likely in families with a known history of the condition or in relatives having children together.
Inheritance of HSPG2 variants
HSPG2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the HSPG2 gene from each parent, and both parents are typically healthy carriers. When both parents carry an HSPG2 gene variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child without the familial variant. In practical terms, how HSPG2 variants are inherited is the same for sons and daughters because this gene is on a non-sex chromosome.
What does my HSPG2 result mean for my family?
For families with an HSPG2-related condition, the pattern is usually recessive, which often means parents are healthy carriers and brothers or sisters may also be carriers or may be affected. Close relatives may share the same gene change, especially siblings. This can matter for family planning, because carrier relatives can pass the change on to their children.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the HSPG2 gene looks for DNA variants using a blood sample, saliva, or a cheek swab. A laboratory reads the gene’s sequence and compares it with the usual pattern to find changes that may help explain a person’s condition or family history. Results may show a pathogenic variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
If there is a family history of HSPG2-related conditions, or a child has ongoing muscle stiffness along with bone or joint growth problems, genetic testing may help confirm the cause. It can also help clarify carrier status when planning a pregnancy.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they reveal depends on the condition and on the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. For certain conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put a person’s own experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than others, while some are more or less sensitive to its effects. This helps explain why the same treatment works well for one person but causes fewer benefits or more side effects in another. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes affect a person’s response to medicines. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can help support treatment decisions that are more informed and more individualized. For a closer look at this topic, more information is available in the LearnHub.
Drugs influenced by the HSPG2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
The HSPG2 gene entered the medical literature through studies of perlecan, a large protein identified in basement membranes in the 1980s. Researchers first purified and named perlecan before linking it to a specific gene, and this helped connect tissue structure research with human genetics. In the 1990s, scientists mapped and sequenced the HSPG2 gene, which clarified its place in inherited conditions affecting bone growth and muscle stiffness. Building on this early work, scientists uncovered more about the gene when HSPG2 variants were found in Schwartz-Jampel syndrome and later in dyssegmental dysplasia, Silverman-Handmaker type. These discoveries turned HSPG2 from a basic science finding into a clinically important gene. Over time, descriptions became more precise as genetic testing improved and more families were studied.